Invitae Corp
NYSE:NVTA
Invitae Corp
Revenue
Invitae Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Invitae Corp
NYSE:NVTA
|
Revenue
$481.6m
|
CAGR 3-Years
25%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$357.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
Cigna Corp
NYSE:CI
|
Revenue
$195.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
32%
|
CAGR 10-Years
20%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
8%
|
Invitae Corp
Revenue Breakdown
Breakdown by Geography
Invitae Corp
Total Revenue:
516.3m
USD
|
United States:
457.1m
USD
|
Rest Of World:
35.8m
USD
|
United Kingdom:
9.2m
USD
|
Canada:
8.8m
USD
|
Germany:
5.4m
USD
|
Breakdown by Segments
Invitae Corp
Total Revenue:
516.3m
USD
|
Test Revenue:
500.6m
USD
|
Oncology:
308.5m
USD
|
Women's Health:
95.8m
USD
|
Rare Diseases:
66m
USD
|
Data/Services:
15.7m
USD
|
See Also
What is Invitae Corp's Revenue?
Revenue
481.6m
USD
Based on the financial report for Sep 30, 2023, Invitae Corp's Revenue amounts to 481.6m USD.
What is Invitae Corp's Revenue growth rate?
Revenue CAGR 5Y
30%
Over the last year, the Revenue growth was -7%. The average annual Revenue growth rates for Invitae Corp have been 25% over the past three years , 30% over the past five years .